Longitudinal Immune-phenotyping of HCC Following MK-3475
Clinical trial NCT04224480 · UNKNOWN
Trial details
- NCT number
- NCT04224480
- Sponsor
- National Cancer Centre, Singapore
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-10
- Primary completion
- 2025-12-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.